Pharmaceutical companies are highly dependent on the successful launch of new drugs with the potential to become billion dollar ‘blockbusters’
But to evaluate the potential of each firm, the major business segments – all of which are often included in the product line-up of the Majors – should be considered
- Pharmaceuticals
- Medical Devices and Diagnostics
- Consumer Products
The strategic choices underpinning the mix between the segments – and the shifts decided over time - are in many ways indicative of the broad trends commanding the pharmaceutical industry
